News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
286,342 Results
Type
Article (15159)
Company Profile (298)
Press Release (270877)
Multimedia
Podcasts (94)
Webinars (12)
Section
Business (79940)
Career Advice (164)
Deals (13382)
Drug Delivery (43)
Drug Development (50797)
Employer Resources (31)
FDA (5888)
Job Trends (5184)
News (145329)
Policy (10080)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (3)
Academia (937)
Accelerated approval (25)
Adcomms (14)
Allergies (99)
Alliances (21763)
ALS (157)
Alzheimer's disease (1110)
Antibody-drug conjugate (ADC) (352)
Approvals (6145)
Artificial intelligence (336)
Autoimmune disease (210)
Automation (10)
Bankruptcy (105)
Best Places to Work (4561)
BIOSECURE Act (6)
Biosimilars (117)
Biotechnology (230)
Bladder cancer (117)
Brain cancer (57)
Breast cancer (402)
Cancer (3769)
Cardiovascular disease (277)
Career advice (150)
Career pathing (8)
CAR-T (255)
CDC (6)
Celiac Disease (1)
Cell therapy (670)
Cervical cancer (21)
Clinical research (44539)
Collaboration (1394)
Company closure (3)
Compensation (716)
Complete response letters (54)
COVID-19 (1117)
CRISPR (102)
C-suite (713)
Cystic fibrosis (117)
Data (5308)
Denatured (19)
Depression (109)
Dermatology (48)
Diabetes (295)
Diagnostics (1424)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (244)
Drug pricing (52)
Drug shortages (3)
Duchenne muscular dystrophy (261)
Earnings (32422)
Editorial (31)
Employer branding (4)
Employer resources (29)
Events (52871)
Executive appointments (674)
FDA (7963)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1145)
Gene editing (217)
Generative AI (29)
Gene therapy (579)
GLP-1 (549)
Government (1176)
Grass and pollen (3)
Guidances (172)
Healthcare (6656)
HIV (26)
Huntington's disease (50)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (83)
Immunology and inflammation (228)
Immuno-oncology (69)
Indications (120)
Infectious disease (1261)
Inflammatory bowel disease (181)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (195)
Interviews (18)
IPO (7359)
IRA (13)
Job creations (868)
Job search strategy (130)
JPM (41)
Kidney cancer (9)
Labor market (26)
Layoffs (250)
Leadership (11)
Legal (1403)
Liver cancer (44)
Longevity (23)
Lung cancer (496)
Lymphoma (281)
Machine learning (33)
Management (7)
Manufacturing (479)
MASH (150)
Medical device (2694)
Medtech (2709)
Mergers & acquisitions (6728)
Metabolic disorders (851)
mRNA (145)
Multiple sclerosis (119)
NASH (14)
Neurodegenerative disease (298)
Neuropsychiatric disorders (81)
Neuroscience (2211)
Neurotech (1)
NextGen: Class of 2026 (2036)
Non-profit (875)
Now hiring (38)
Obesity (385)
Opinion (138)
Ovarian cancer (166)
Pain (128)
Pancreatic cancer (205)
Parkinson's disease (280)
Partnered (12)
Patents (368)
Patient recruitment (466)
Peanut (46)
People (27060)
Pharmaceutical (42)
Pharmacy benefit managers (6)
Phase 1 (15782)
Phase 2 (20732)
Phase 3 (13062)
Pipeline (5144)
Policy (101)
Postmarket research (853)
Preclinical (6703)
Press Release (30)
Prostate cancer (183)
Psychedelics (57)
Radiopharmaceuticals (270)
Rare diseases (820)
Real estate (1454)
Recruiting (12)
Regulatory (10395)
Reports (20)
Research institute (981)
Resumes & cover letters (20)
Rett syndrome (32)
RNA editing (25)
RSV (24)
Schizophrenia (144)
Series A (224)
Series B (154)
Service/supplier (1)
Sickle cell disease (89)
Special edition (19)
Spinal muscular atrophy (124)
Sponsored (17)
Startups (2024)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (19)
The Weekly (73)
Vaccines (382)
Venture capital (83)
Weight loss (205)
Women's health (42)
Worklife (2)
Date
Today (162)
Last 7 days (522)
Last 30 days (1803)
Last 365 days (18031)
2026 (6427)
2025 (18097)
2024 (20539)
2023 (22412)
2022 (26821)
2021 (27807)
2020 (23357)
2019 (16224)
2018 (11735)
2017 (13746)
2016 (11838)
2015 (14350)
2014 (10394)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7429)
Location
Africa (154)
Alabama (71)
Alaska (2)
Arizona (82)
Arkansas (6)
Asia (18550)
Australia (3181)
California (8118)
Canada (2098)
China (932)
Colorado (293)
Connecticut (306)
Delaware (277)
Europe (39873)
Florida (1039)
Georgia (239)
Hawaii (2)
Idaho (17)
Illinois (474)
India (43)
Indiana (191)
Iowa (8)
Japan (279)
Kansas (82)
Kentucky (11)
Louisiana (12)
Maine (12)
Maryland (846)
Massachusetts (6435)
Michigan (122)
Minnesota (287)
Mississippi (3)
Missouri (35)
Montana (17)
Nebraska (6)
Nevada (43)
New Hampshire (22)
New Jersey (1867)
New Mexico (13)
New York (2020)
North Carolina (949)
North Dakota (6)
Northern California (4079)
Ohio (204)
Oklahoma (11)
Oregon (23)
Pennsylvania (1497)
Puerto Rico (11)
Rhode Island (27)
South America (216)
South Carolina (12)
Southern California (3249)
Tennessee (49)
Texas (1086)
United States (26848)
Utah (111)
Virginia (169)
Washington D.C. (37)
Washington State (669)
West Virginia (1)
Wisconsin (52)
286,342 Results for "soleno therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
While an acquisition is a good exit for Soleno Therapeutics, the company’s acceptance of Neurocrine Biosciences’ $53-per-share offer came as a surprise to Stifel analysts given the potential growth of Vykat XR, approved last year for extreme hunger in patients with Prader-Willi syndrome.
April 6, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
April 6, 2026
·
18 min read
Press Releases
Soleno Therapeutics to Participate in Upcoming Conferences - January 29, 2026
January 29, 2026
·
1 min read
Press Releases
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
February 26, 2026
·
4 min read
Press Releases
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
January 12, 2026
·
6 min read
Press Releases
Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
February 26, 2026
·
12 min read
Press Releases
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
February 11, 2026
·
2 min read
Press Releases
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
December 4, 2025
·
3 min read
Press Releases
Soleno Therapeutics to Participate in Upcoming November 2025 Conferences
October 29, 2025
·
1 min read
Press Releases
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
·
1 min read
1 of 28,635
Next
